UBS AM’s Krystal Biotech KRYS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $32.2M | Sell |
234,320
-341,186
| -59% | -$46.9M | 0.01% | 851 |
|
|
2025
Q1 | $104M | Buy |
575,506
+365,304
| +174% | +$65.9M | 0.03% | 527 |
|
|
2024
Q4 | $32.9M | Sell |
210,202
-14,743
| -7% | -$2.31M | 0.01% | 777 |
|
|
2024
Q3 | $40.9M | Sell |
224,945
-26,817
| -11% | -$4.88M | 0.01% | 715 |
|
|
2024
Q2 | $46.2M | Buy |
251,762
+233,501
| +1,279% | +$42.9M | 0.01% | 636 |
|
|
2024
Q1 | $3.25M | Sell |
18,261
-2,165
| -11% | -$385K | ﹤0.01% | 1456 |
|
|
2023
Q4 | $2.53M | Hold |
20,426
| – | – | ﹤0.01% | 1568 |
|
|
2023
Q3 | $2.37M | Buy |
20,426
+3,633
| +22% | +$421K | ﹤0.01% | 1535 |
|
|
2023
Q2 | $1.34M | Hold |
16,793
| – | – | ﹤0.01% | 1869 |
|
|
2023
Q1 | $1.34M | Buy |
16,793
+1,322
| +9% | +$106K | ﹤0.01% | 1869 |
|
|
2022
Q4 | $1.23M | Sell |
15,471
-701
| -4% | -$55.5K | ﹤0.01% | 1756 |
|
|
2022
Q3 | $1.13M | Buy |
16,172
+965
| +6% | +$67.3K | ﹤0.01% | 1896 |
|
|
2022
Q2 | $998K | Hold |
15,207
| – | – | ﹤0.01% | 1964 |
|
|
2022
Q1 | $1.01M | Buy |
15,207
+5,014
| +49% | +$334K | ﹤0.01% | 2133 |
|
|
2021
Q4 | $713K | Buy |
10,193
+1,488
| +17% | +$104K | ﹤0.01% | 2384 |
|
|
2021
Q3 | $454K | Hold |
8,705
| – | – | ﹤0.01% | 2535 |
|
|
2021
Q2 | $592K | Sell |
8,705
-662
| -7% | -$45K | ﹤0.01% | 2468 |
|
|
2021
Q1 | $722K | Sell |
9,367
-1,300
| -12% | -$100K | ﹤0.01% | 2235 |
|
|
2020
Q4 | $640K | Hold |
10,667
| – | – | ﹤0.01% | 2200 |
|
|
2020
Q3 | $459K | Buy |
10,667
+5,267
| +98% | +$227K | ﹤0.01% | 2182 |
|
|
2020
Q2 | $224K | Sell |
5,400
-467
| -8% | -$19.3K | ﹤0.01% | 2356 |
|
|
2020
Q1 | $254K | Buy |
5,867
+1,767
| +43% | +$76.4K | ﹤0.01% | 2206 |
|
|
2019
Q4 | $227K | Buy |
+4,100
| New | +$227K | ﹤0.01% | 2444 |
|